Titel

Merkliste
1 Ergebnisse

Intermittent PI3Ko inhibition sustains anti-tumor immunity ..:

Eschweiler, S ; Ramirez-Suastegui, C ; Li, Y...
Eschweiler S, Ramírez-Suástegui C, Li Y et al (2022) Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs. Nature. 605: 741-746.. , 2022

Link: http://hdl.handle.net/10454/18980

RT Journal
T1 <Title>Intermittent PI3Ko inhibition sustains anti-tumor immunity and curbs irAEs</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivbradford:oai:bradscholars.brad.ac.uk:10454_18980&Exemplar=1&LAN=DE
				
A1 Eschweiler, S
A1 Ramirez-Suastegui, C
A1 Li, Y
A1 King, E
A1 Chudley, L
A1 Thomas, J
A1 Wood, O
A1 von Witzleben, A
A1 Jeffrey, D
A1 McCann, K
A1 Simon, H
A1 Mondal, M
A1 Wang, A
A1 Dicker, M
A1 Lopez-Guadamillas, E
A1 Chou, T.-F
A1 Dobbs, N.A
A1 Essame, L
A1 Acton, G
A1 Kelly, F
A1 Halbert, G
A1 Sacco, J.J
A1 Schache, A.G
A1 Shaw, R
A1 McCaul, J.A
A1 Paterson, C
A1 Davies, J.H
A1 Brennan, Peter A
A1 Singh, R.P
A1 Loadman, Paul
A1 Wilson, W
A1 Hackshaw, A
A1 Seumois, G
A1 Okkenhaug, K
A1 Thomas, G.J
A1 Jones, T.M
A1 Ay, F
A1 Friberg, G
A1 Kronenberg, M
A1 Vanhaesebroeck, B
A1 Vijayananad, P
A1 Ottensmeier, C.H
YR 2022
K1 PI3Kδ inhibition
K1 AMG319
K1 Head and neck surgery
K1 Immunotherapy
K1 Research Development Fund Publication Prize Award
JF Eschweiler S, Ramírez-Suástegui C, Li Y et al (2022) Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs. Nature. 605: 741-746.
LK http://hdl.handle.net/10454/18980
DO http://hdl.handle.net/10454/18980
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)